health news today obesity drugs glp-1 Use of to Treat Overweight or Increased 587 Percent from 2019 to 2024, According to New FAIR Study World Health Organization issues first-ever

In many places, telehealth doctors and nurses are legally allowed to treat patients across state lines

The GLP-1 component reaches a threshold level that produces noticeable changes in hunger patterns and food preferences

8 Excellent sources of fiber include: Whole grains (oats, quinoa, brown rice, barley, whole wheat bread/pasta) 12 Legumes (beans, lentils, chickpeas, peas) 12 Fruits (especially berries, apples, pears with skin) 12 Vegetables (broccoli, Brussels sprouts, carrots, leafy greens, bell peppers) 12 Nuts and seeds (chia seeds, flaxseeds, almonds, walnuts) 12 Psyllium husk can also be considered as a fiber supplement

Food and Drug Administration (FDA) has approved four GLP-1 drugs for weight loss in people with overweight or obesity: liraglutide (Saxenda) orforglipron (Foundayo) semaglutide (Wegovy) tirzepatide (Zepound) Liraglutide, semaglutide, and tirzepatide are injectable medications that come in prefilled pens

Finally, what factors do we need to consider in our healthcare system to ensure that patients have appropriate (and likely chronic) access to expensive biologic medications

Non-clinical and first-in-human characterization of ECC5004/AZD5004, a novel once-daily, oral small-molecule GLP-1 receptor agonist